Huntington National Bank Novo Cure LTD Transaction History

Huntington National Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$40.29 - $82.51 $1,248 - $2,557	31 New	31 $1,000
Q4 2022 Feb 09, 2023	BUY	$63.98 - $85.37 $959 - $1,280	15 Added 88.24%	32 $2,000
Q3 2022 Nov 07, 2022	SELL	$67.99 - $89.57 $203 - $268	-3 Reduced 15.0%	17 $1,000
Q2 2022 Aug 09, 2022	BUY	$56.6 - $89.9 $396 - $629	7 Added 53.85%	20 $1,000
Q1 2022 May 10, 2022	BUY	$60.15 - $84.52 $421 - $591	7 Added 116.67%	13 $1,000
Q4 2021 Jan 21, 2022	BUY	$75.08 - $121.99 $450 - $731	6 New	6 $0

265

76.7M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.48B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

Stay updated on Huntington National Bank with notifications on news.